Hiroyuki Hanzawa

Identification of a ubiquitin–protein ligase subunit within the CCR4–NOT transcription repressor complex

Thomas Albert, Hiroyuki Hanzawa, Yvonne I.A. Legtenberg et al. · The EMBO Journal · 2002 · 216 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Phomactin A; a novel PAF antagonist from a marine fungus Phoma sp

Michihiro Sugano, Aiya Sato, Yasuteru Iijima et al. · Journal of the American Chemical Society · 1991 · 162 citations

Life Sciences, Botany, Pharmacology +10

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Ryohei Katayama, Bo Gong, Noriko Togashi et al. · Nature Communications · 2019 · 141 citations · Full text

Medicine, Oncology, Pharmacology +15

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

Shin-ichiro Miura, Masahiro Fujino, Hiroyuki Hanzawa et al. · Journal of Biological Chemistry · 2006 · 126 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Erkut Borazanci, Alice T. Shaw et al. · Clinical Cancer Research · 2020 · 108 citations · Full text

Medicine, Oncology, Pharmacology +15